Publications by authors named "Barbara Stecca"

Claim this Profile
P
PHGDH drives 5-FU chemoresistance in colorectal cancer through the Hedgehog signaling.
Caterina Mancini, Giulia Lori, Gianluca Mattei, Marta Iozzo, Dayana Desideri, Barbara Stecca

J Exp Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MEK5/ERK5 pathway promotes the activation of the Hedgehog/GLI signaling in melanoma cells.
Ignazia Tusa, Sinforosa Gagliardi, Alessio Menconi, Luisa Maresca, Alessandro Tubita, Barbara Stecca

Cell Oncol (Dordr)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP1 in melanoma: Mechanistic insights and implications for basic and clinical research.
Andrea Marranci, Luisa Maresca, Samuele Lodovichi, Andrea Ghelli Luserna di Rorà, Barbara Stecca

Cancer Lett· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importin subunit beta-1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation.
Zoe Lombardi, Lucia Gardini, Anatolii V Kashchuk, Alessio Menconi, Matteo Lulli, Barbara Stecca

Mol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latent-Transforming Growth Factor β-Binding Protein 1/Transforming Growth Factor β1 Complex Drives Antitumoral Effects upon ERK5 Targeting in Melanoma.
Alessandro Tubita, Alessio Menconi, Zoe Lombardi, Ignazia Tusa, Azucena Esparís-Ogando, Barbara Stecca

Am J Pathol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma.
Alessandro Giammona, Chiara De Vellis, Enrica Crivaro, Luisa Maresca, Roberta Amoriello, Barbara Stecca

J Exp Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth.
Luisa Maresca, Enrica Crivaro, Francesca Migliorini, Giulia Anichini, Alessandro Giammona, Barbara Stecca

Pharmacol Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma.
Silvia Pietrobono, Barbara Stecca

Oncotarget· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma.
Giulia Anichini, Chiara Raggi, Mirella Pastore, Laura Carrassa, Luisa Maresca, Barbara Stecca

Mol Cancer Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Roles of Hedgehog Signaling in Cancer Immunity.
Alessandro Giammona, Enrica Crivaro, Barbara Stecca

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells.
Silvia Pietrobono, Raffaella De Paolo, Domenico Mangiameli, Andrea Marranci, Ilaria Battisti, Barbara Stecca

J Biol Chem· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinolines and Oxazino-quinoline Derivatives as Small Molecule GLI1 Inhibitors Identified by Virtual Screening.
Fabrizio Manetti, Luisa Maresca, Enrica Crivaro, Sara Pepe, Elena Cini, Barbara Stecca

ACS Med Chem Lett· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment.
Luisa Maresca, Barbara Stecca, Laura Carrassa

Cells· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21.
Alessandro Tubita, Zoe Lombardi, Ignazia Tusa, Azzurra Lazzeretti, Giovanna Sgrignani, Barbara Stecca

Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.
Ignazia Tusa, Sinforosa Gagliardi, Alessandro Tubita, Silvia Pandolfi, Alessio Menconi, Barbara Stecca

Int J Mol Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of the Hedgehog Pathway in Cholangiocarcinoma.
Giulia Anichini, Laura Carrassa, Barbara Stecca, Fabio Marra, Chiara Raggi

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAPK15 Controls Hedgehog Signaling in Medulloblastoma Cells by Regulating Primary Ciliogenesis.
Silvia Pietrobono, Lorenzo Franci, Francesco Imperatore, Cristina Zanini, Barbara Stecca

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Glycosylation in Melanoma Progression.
Chiara De Vellis, Silvia Pietrobono, Barbara Stecca

Cells· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma.
Silvia Pietrobono, Eugenio Gaudio, Sinforosa Gagliardi, Mariapaola Zitani, Laura Carrassa, Barbara Stecca

Oncogene· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
Silvia Pietrobono, Barbara Stecca

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis.
Valentina Montagnani, Luisa Maresca, Alessandro Apollo, Sara Pepe, Ryan M Carr, Barbara Stecca

J Biol Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL.
Silvia Pietrobono, Giulia Anichini, Cesare Sala, Fabrizio Manetti, Luciana L Almada, Barbara Stecca

Nat Commun· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells.
Elena Andreucci, Silvia Peppicelli, Jessica Ruzzolini, Francesca Bianchini, Alessio Biagioni, Barbara Stecca

J Mol Med (Berl)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacophore-Based Virtual Screening for Identification of Negative Modulators of GLI1 as Potential Anticancer Agents.
Fabrizio Manetti, Barbara Stecca, Roberta Santini, Luisa Maresca, Giuseppe Giannini

ACS Med Chem Lett· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened.
Silvia Pietrobono, Sinforosa Gagliardi, Barbara Stecca

Front Genet· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis